Back
Aclaris Therapeutics Vs. Aldeyra Therapeutics Industry Stock Comparison
Sell
26
ACRS
Aclaris Therapeutics
Last Price:
1.36
Seasonality Move:
4.39%
Buy
56
ALDX
Aldeyra Therapeutics
Last Price:
4.16
Seasonality Move:
16.08%
Sell
26
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.36. The Score for ACRS is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Aldeyra Therapeutics (ALDX)
is a Buy
Is Aldeyra Therapeutics a Buy, Sell or Hold?
- The current Aldeyra Therapeutics [ALDX] share price is $4.16. The Score for ALDX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- ALDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.36
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACRS is experiencing slight buying pressure.
ALDX Stock Price Chart
What is Aldeyra Therapeutics's stock price today?
-
The Aldeyra Therapeutics share price today is $4.16
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALDX is experiencing slight selling pressure.
ACRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 67.97 | Buy |
| Chaikin Money Flow: | 76464 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.19 - 1.27) | Buy |
| Bollinger Bands (100): | (1.08 - 1.28) | Buy |
ALDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 57.92 | Buy |
| Chaikin Money Flow: | -66892 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.78 - 4.4) | Buy |
| Bollinger Bands (100): | (3.02 - 3.96) | Buy |
ACRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.24 | Buy |
| 20-day SMA: | 1.22 | Buy |
| 50-day SMA: | 1.23 | Buy |
| 200-day SMA: | 3.53 | Sell |
| 8-day EMA: | 1.27 | Buy |
| 20-day EMA: | 1.24 | Buy |
| 50-day EMA: | 1.26 | Buy |
| 200-day EMA: | 3.51 | Sell |
ALDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.05 | Buy |
| 20-day SMA: | 4.09 | Buy |
| 50-day SMA: | 3.71 | Buy |
| 200-day SMA: | 4.35 | Sell |
| 8-day EMA: | 4.08 | Buy |
| 20-day EMA: | 3.99 | Buy |
| 50-day EMA: | 3.78 | Buy |
| 200-day EMA: | 4.4 | Sell |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.55 per share, and an increase next year of $0.30 per share.
Aldeyra Therapeutics Earnings Growth & ALDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and a decrease next year of $0.02 per share.
Aclaris Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aldeyra Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||